The Recall Desk
CriticalFDA (Drugs)·D-0102-2018·Announced 2017-12-13

Pravastatin Tablets Recalled Due to Incorrect Bupropion Filling

International Laboratories is recalling Pravastatin Sodium Tablets 40 mg because they were filled with Bupropion hydrochloride XL Tablets 300 mg.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 per the rubric.

Plain-English summary

International Laboratories, Inc. is recalling Pravastatin Sodium Tablets, USP, 40 mg, 30-count bottles. The recall is due to a labeling mix-up where the product labeled as Pravastatin was filled with Bupropion hydrochloride XL Tablets 300 mg.

The affected product is identified by Lot # 115698A and an expiration date of 02/19. The NDC is 54458-925-16. A total of 82,056 bottles were distributed nationwide in the U.S.A. and in Puerto Rico.

Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on obtaining the correct medication.

The recalled product

Product
Pravastatin Sodium Tablets, USP, 40 mg, 30-count bottle, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-925-16
Affected units
82,056

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 115698A
  • Exp 02/19

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Same manufacturer · International Laboratories, Inc.

See all →